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Objective: The first endovascular stent graft was implanted to treat an abdominal aortic aneurysm more than a decade ago.
This technique has evolved dramatically with the growing understanding of metallurgic and fabric sciences and improved
device designs. However the potential for stent graft material failure remains. This investigation describes the incidence
of material failure, potential modes of device fatigue, and the clinical significance of these failures.
Methods: Six hundred eighty-six endovascular stent grafts were used to treat patients with aortic aneurysms. Device fatigue
in the form of stent, suture fracture, or graft wear was identified with an analysis of follow-up radiographs and explanted
stent grafts. A review of patient clinical histories, spiral computed tomographic scan studies, scanning electron
microscopy, and energy dispersion spectroscopy of explanted devices was conducted to evaluate the modes and
consequences of failure.
Results: Sixty patients were identified with device fatigue, 49 of whom had abdominal endovascular repairs and 11 of
whom had thoracic repairs. Of the 60 patients with stent graft fatigue, 43 patients had metallic stent fractures, 14 had
suture disruptions, and three had graft holes. These material failures occurred within seven distinct stent graft designs.
The average time to the recognition of failure was 19 months, with a mean follow-up period of 8 months since the event
was identified. Eleven patients died, and one was lost to follow-up 2 years after identification of a stent fracture. The
remaining patients are presently being followed eoyj physical examination, plain film radiograph, and computed
tomographic scans for clinical sequelae of device fatigue.
Conclusion: Endovascular stent graft fatigue has been recognized in numerous devices after aortic implantation. Fatigue
may take the form of stent, graft, or suture failure, with certain modes unique to specific stent graft devices. The clinical
significance of stent graft material failure remains uncertain. (J Vasc Surg 2003;37:16-26.)
The first endovascular stent graft repair to treat an
abdominal aortic aneurysm was performed by Parodi,
Palmaz, and Barone1 more than a decade ago. An estimated
greater than 25,000 aortic stent grafts have since been
deployed worldwide, and although preliminary results have
been promising, problems with deployment, stent graft
migration, endoleak, material failure, and aneurysm rup-
ture have all been reported.2-7 Many of these problems
were seen with first generation stent grafts. Fundamental
mechanical and technical device problems have been ad-
dressed, and individual implants have been improved.
However, as midterm results of second-generation endo-
vascular grafts are reported, new problems are discovered.
Device fatigue remains one of the most concerning
modes for potential procedure failure, encompassing the
breakdown of the intrinsic mechanical parts of the stent
graft. It is often difficult to identify device fatigue because
patients are typically asymptomatic at the time of presenta-
tion. This difficulty has made a true understanding of the
magnitude of the problem challenging. Moreover, the clin-
ical significance of many identified material failures is un-
known. The purpose of this study was to analyze a large
single experience of endovascular aortic repairs to identify
the incidence of device fatigue and the potential modes of
fatigue and to try and determine the clinical significance of
these material failures.
METHODS
Study population
Six-hundred eighty-six patients underwent endovascu-
lar aortic aneurysm repair over a 10-year period, 39 of
which were implanted by the senior author while attending
at the Montefiore Medical Center and the remaining 647
performed at the Mount Sinai Medical Center. Four hun-
dred four of these patients had a full compliment of fol-
low-up analyses for review and form the study set for this
investigation. A total of 60 patients (15%) of this subset had
stent graft fatigue as identified with radiographic studies or
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the analysis of an explanted stent graft device. Patients were
followed at 1, 3, 6, and 12 months and annually thereafter,
in accordance with the specific US Food and Drug Admin-
istration protocols for each device, with physical examina-
tion, plain film radiographs, duplex ultrasonography, and
spiral computed tomographic (CT) scans. The median
follow-up period was 30 months, with a range from 1 to 52
months. The information obtained from these visits and the
results of the radiologic studies were analyzed for evidence
of device fatigue. Device fatigue was defined as an actual
change in the mechanical nature of the device, such as
suture disruption, metal fracture, or fabric erosion. Proce-
dure failure was defined as a repressurization of the aneu-
rysm sac or rupture of the aneurysm.
Techniques for endovascular repair
The three techniques used for aortic aneurysm repair
included: tubular (aortoaortic), aortouniiliac, bifurcated-
Table I. Distribution of stent graft fatigue by device
Device for aortic
aneurysm repair
Total
implanted
Radiographs
reviewed
Total fatigue/
fracture
Average time to fracture/
fatigue (mo; range)
Average follow-up since
fracture/fatigue (mo; range)†
Abdominal
Vanguard 26 22 (85%) 16 (72%) 26* (3-48) 13 (1-39)
Talent 337 232 (69%) 24 (10%) 13 (1-31) 5 (1-12)
Modified Parodi 164 24 (15%) 5 (21%) 38 (33-48) 6 (1-8)
EVT/Ancure 9/20 7/6 1/0 (14%) 8 24 and then lost to follow-up
AneuRx 39 33 (85%) 3 (10%) 10 (1-24) 3 (1-6)
Gore 18 18 (100%) 0
Teramed 10 10 (100%) 0
Thoracic
Gore TAG 22 19 (86%) 7 (37%) 24 (3-38) 12 (1-42)
Talent 41‡ 33 (80%) 4 (12%) 9.5 (1-24) 4 (2-7)
Total 686 404 60 19 8
*Excluding patient with acute conversion.
†Excluding those patients who underwent open conversion and stent graft explanation.
‡Including emergent use not part of clinical study.
Table II. Failure mode analysis by device
Device
No.
fatigued Location No.
Average time to fatigue
(mo; range)
AAA 49
Talent 24 Graft hole 1 16
Metal stent fracture 23 13 (1-31)
Longitudinal bar 14
Aortic body: proximal 7
Aortic body: distal 1
Iliac 6
Proximal transrenal stent 5
Z-shaped body stent 4
Vanguard 16 Suture disruption 14 25 (3-48)
Row separation 5
Body separation 9
Graft hole 2 Intraoperative & 36
EVT 1 Hooks and shanks 1 8
Modified
Parodi
5 Metal stent fracture 5 38 (33-48)
Top row of stent 4
Second row 1
AneuRx 3 Metal stent fracture 3 10 (1-24)
TAA 11
Gore 7 Metal stent fracture 7 24 (3-38)
Isolated longitudinal bar 3
Longitudinal bar and z-stent 2
Z-stent 2
Talent 4 Metal stent fracture 4 9.5 (1-24)
Z-stent 3
Longitudinal bar 1
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm.
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modular, and bifurcated-unibody. All of these techniques
have been demonstrated in detail previously.8-13
Devices for abdominal aortic aneurysm and thoracic
aortic aneurysm repair
Seven different devices were used to treat patients with
abdominal aortic aneurysms, and two for thoracic aortic
aneurysms. Extensive descriptions have been provided in
the literature of the nine devices used: Talent,14,15 Van-
guard,14,16 Parodi-Modified Endovascular stent graft,13
EVT,10,17 AneuRx,18 Gore Excluder,19 Cordis Quantum
LP,20 and the Talent and Gore thoracic devices.21
Stent graft analysis
Radiographic studies. Plain film radiographs and CT
scans were performed at 1, 6, and 12 months and annually
thereafter. CT scanning consisted of a noncontrast exami-
nation followed by a dynamic CT angiogram to evaluate for
Fig 1. Clinical examples of fatigue in Talent endovascular system. A, After persistent type I endoleak, 70-year-old man
had endovascular graft explanted and conventional repair completed. Explanted graft showed signs of graft wear with
frayed fabric yarns and creation of defined hole (arrow). B, Proximal longitudinal bar fracture in Talent endovascular
graft (arrow). C, Distal aortic longitudinal bar fracture (arrow). D, Ipsilateral limb longitudinal bar fracture in Talent
endovascular graft. (Continued.)
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endoleaks or changes in aneurysm size. Plain films were
used to analyze the stent components of the stent graft.
Initially two views, anteroposterior and lateral, were used;
however, over the past 2 years, right posterior oblique and
left anterior oblique views have been added to improve
visualization of the structural components of the device
Explant analysis. Five grafts with device fatigue were
available for explant analysis after open surgical conversion.
The device was first inspected macroscopically for evidence
of stent fracture, fabric tears, or suture breaks, and then
representative regions of the metal stent were studied with
scanning electron microscopy (SEM).
Preparation of specimens for SEM. Explanted stent
grafts were rinsed of remaining debris and fixed in buffered
formaldehyde. Each specimen was rinsed in distilled water
and air dried for 24 hours. Representative regions of the
metallic stent were ultrasonicated in a mild cleaning agent
for 10 minutes, rinsed in distilled water, and ultrasonicated
in absolute alcohol for another 10 minutes. The specimens
were mounted on SEM stubs with silver paint. A Hitachi
S530 SEM was used to evaluate the metal surface for
defects and to analyze the site of fracture for evidence of
fatigue. Energy dispersion spectroscopy (EDS) analysis was
used at 15 kV on selected specimens to determine the
surface composition of the metal and to assess for metal
leaching.
RESULTS
Sixty patients (49 men and 11 women) were identified
with device fatigue, 55 on radiographic analysis and five on
explantation. Forty-nine of the devices with fatigue were
seen in abdominal aortic aneurysm stent grafts, and 11 were
found in thoracic aortic stent grafts. The 60 fatigued stent
grafts in this study were distributed among seven different
devices (Table I). The average time to fatigue for all devices
combined was 19 months (range, 1 to 48 months), with an
average follow-up period since fatigue identification of 8
months. A marked variation in the time to failure was seen
depending on the type of fatigue (ie, suture fracture, graft
holes, or stent fractures; Table II). Eleven of the 60 patients
followed with device fatigue have died, and one patient was
lost to follow-up 2 years after fatigue was identified. Of the
11 deaths, three were device related, and the remaining eight
patients died of causes unrelated to their aortic aneurysms.
Excluding one early postoperative death, the average time to
death was 29 months (range, 17 to 52 months) after implan-
tation and 13 months (range, 2 to 26 months) after fatigue
was first identified. The remaining patients continue to be
followed for clinical sequelae of their stent graft fatigue.
Stent graft fatigue analyzed by device
Abdominal aorta stent grafts. Twenty-four of the 60
patients with device fatigue had Talent grafts inserted (Ta-
ble II). Fatigue was recognized within several different
regions of the stent graft. One patient had a wear hole
detected in an explanted prosthesis at the site of graft to
stent fixation (Fig 1, A). The remaining Talent endografts
had fractured stents. Fourteen fractures occurred along the
longitudinal bar of the graft (Fig 1, B to D), and nine in the
serpentine shaped nitinol (Fig 1, E, F).
Device fatigue was identified in 16 Vanguard abdomi-
nal aortic aneurysm stent grafts; 14 had evidence of suture
disruption, and two had fabric wear holes (Fig 2, A to D).
The remaining nine fatigues were metal fractures: one EVT
device (Fig 3), five modified Parodi endovascular stent
grafts (Fig 4), and three AneuRx devices (Fig 5). Metal
fatigue within AneuRx grafts was difficult to conclusively
identify on plain film examination because of overlapping
Fig 1, continued. E, Midbody z stent fracture (arrow). F, Proximal transrenal stent fracture in Talent endovascular
graft. Note fracture has occurred adjacent to site of nitinol wire crimp, which contains two ends of z-configured stent.
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metal densities of the stent and the relatively close diamond
pattern.
Thoracic aorta stent grafts. Eleven of the 60 cases
with device fatigue were metal fractures in thoracic aortic
stent graft devices: seven Gore TAG and four Talent.
Although the seven TAG devices had fractures in either the
longitudinal bar, the z-shaped stent, or both (Fig 6), the
four Talent thoracic aortic aneurysm devices had fractures
in the z-shaped stents only.
Endoleaks
Endoleaks were identified in 24 of the 60 patients
(40%) with device fatigue at some point during the fol-
low-up period (Table III). Five (21%) had evidence of
Fig 2. Clinical examples of fatigue in Boston Scientific Vanguard endovascular graft. Sixty-nine-year-old man had
tube graft inserted for repair of abdominal aortic aneurysm. A, Proximal row separation was defined on this graft along
with distal endoleak caused by retraction of prosthesis. B, Graft was explanted, and conventional repair was done at 36
months. Arrow points to site of proximal row separation. C, High-powered magnification of graft depicted in Fig 9, B,
shows fabric fatigue and wear holes on prosthesis surface. D, Seventy-nine-year-old man had endovascular tube graft
placed for repair of abdominal aortic aneurysm. On surveillance abdominal radiographs, suture fractures in body of graft
are detected (arrow). This patient remains in surveillance program.
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fatigue before the endoleak. One patient had proximal and
distal metallic fractures in a first generation EVT stent graft,
and the second patient had a row separation caused by
suture fracture of a Vanguard device that later developed a
type I endoleak from dislodgment of the distal left limb.
The third patient also had a row separation of a Vanguard
tube device and 7 months later was noted to have a type I
endoleak from the proximal and the distal attachment sites.
The fourth patient was noted to have a body separation of
a bifurcated Vanguard device that went on to develop a
type III endoleak from a separation of the modular iliac
limb. The final patient was noted to have a type II endoleak
18 months after a fracture of the third row of the metallic
stents in the AneuRx device was identified.
Eight patients (33%) had stent graft fatigue develop
after the endoleak was diagnosed, and 11 fatigued grafts
(46%) were identified at the same time as an endoleak.
Sixteen patients needed treatment for their endoleaks, two
had spontaneous resolution, and six are currently being
monitored (Table III).
Explants
Five of the six patients who underwent open conversion
had the stent grafts explanted. One patient underwent
conversion at the time of the primary stent graft procedure
for an inadvertent iliac artery rupture with insertion of a
second device to seal a type III endoleak. The remaining
four patients had a new endoleak and an enlarging aortic
aneurysm. The average time to explantation was 28 months
(range, 15 to 36 months).
SEM and EDS analysis
SEM analysis was conducted on all five explanted pros-
theses. Special attention was given to regions of the stent
graft where corrosion would be expected to form (ie,
crimped area of the ends of the nitinol wire stent in the
Talent device, the platinum-nitinol interface of the Van-
guard stent graft, and the high stressed angled regions of
zig-zag nitinol stents; Fig 7, A to C). There was minimal
evidence of corrosion on all the specimens examined. The
stent wire was covered with a relatively uniform oxide
surface layer (Fig 7, D) except for an occasional pit. These
pits were analyzed with EDS, and an apparent decrease in
the nickel concentration on the metal surface was noted.
The expected balanced ratio of titanium to nickel (51%:
49%) was commonly seen in the area immediately subjacent
to the regions with defects (Fig 8, A, B) One explanted
TAG device with a metal fracture was analyzed; the fracture
surface showed cleavage lines within the radius of the stent
typical of stress fatigue (Fig 9).
DISCUSSION
Since the first endovascular stent graft was introduced by
Parodi, Palmaz, and Barone1 over a decade ago, advance-
ments in stent graft materials, designs, and deployment tech-
niques have all contributed to the rapid growth and utility of
these devices. Despite enhanced understanding of the metal-
lurgic and fabric properties of endovascular stent grafts, mate-
rial failure continues to be a potential problem. The inherent
properties of the materials (strength and corrosion resistance)
combined with extrinsic forces contribute significantly to the
risk of device fatigue. Before deployment, and while still in the
delivery sheath, the metallic stent may experience increased
risk for failure based on damage during loading and subse-
quent confinement in the delivery catheter. Once implanted,
the device is then subjected to additional extrinsic forces
imposed by the geometry of the tortuous aorta and the impact
of continuous, high-pressure blood flow. In this study of 60
patients with stent graft fatigue, 43 of the patients had metallic
stent fractures, 14 had suture-stent disruptions, and three had
graft holes. It is useful to analyze these three failure modes
before speculating on the overall clinical significance of stent
graft fatigue.
Fig 3. Attachment system of EVT endovascular grafting system.
Note fracture of hook shank at site of its laser weld on z-configured
attachment system (arrow).
Fig 4. Palmaz balloon expandable proximal stent attachment de-
vice of handmade Parodi-Palmaz system. Note fracture of proximal
diamond row (arrow).
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Metallic fracture
The 43 metallic stent fractures analyzed in this study
occurred in devices fabricated by five different manufactur-
ers. Thirty-seven fractures were documented in superelastic
nitinol (nickel and titanium) stents, five fractures in stain-
less steel (316L) devices, and one in an elgiloy (cobalt-
chromium, nickel) stent.
Elgiloy fractures were initially reported in the hooks of
first generation EVT devices during the early phase of the
EVT trial.17 Even though the hooks were remodeled to a
more gradual angle to decrease the stress applied across the
hook, Najibi et al22 reported two cases of hook fractures
identified 36 months after implantation of the remodeled
Ancure device. Although the EVT device in this study had
Fig 5. Abdominal radiograph of patient who underwent AneuRx
endografting of abdominal aortic aneurysm. Arrow denotes site of
fracture in one of nitinol rings on stent strut.
Fig 6. High-resolution explant radiograph of Gore TAG stent
graft that was used to repair thoracic aortic aneurysm. This patient
was seen 32 months after endovascular repair of thoracic aneurysm
with new endoleak. Endoprosthesis was explanted, and conven-
tional reconstruction was successfully accomplished. Explanted
examination of stent graft with plain film radiograph shows z-
configured wire fractures (arrowheads) and longitudinal bar frac-
ture (arrow).
Table III. Incidence of endoleaks in grafts with device fatigue
Device Endoleak #
Time of diagnosis in relation to fatigue
ManagementBefore After Same time
AAA 20
Vanguard 9 2 3 4 5-Endovascular repair
2-Open repair
2-Observation
Talent 7 5 2 1-Embolization of type II endoleak
3-Open repair
2-Resolved spontaneously
1-Observation
EVT 1 1 1-MEGS A-I-F
Modified
Parodi
1 1 1-Endovascular repair
AneuRx 1 1 1-Observation
TAA 4
Gore 2 2 1-Open repair
1-Observation
Talent 2 2 1-Endovascular repair
1-Refused surgery, died of rupture
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm; MEGS A-I-F, Mount Sinai endovascular stent graft aorto-iliac-femoral.
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similar fractures to the ones reported in the literature, there
was no evidence of fractures in the remodeled Ancure
system. However, the mean follow-up for patients with
Ancure devices in this study was only 13 months.
Stress fatigue is just one of the causes postulated for metal
fractures in these devices. Metal corrosion has been identified
on SEM studies of explanted Stentor grafts, with more severe
corrosive irregularities detected in those devices implanted for
longer period of time.23,24 However, SEM failed to show
significant signs of corrosion in the nitinol stents of this study
and, in fact, revealed a relatively uniform oxide layer on the
surface of the metal stents, which may provide resistance to
corrosion. The lack of corrosion in this study compared with
the results of the earlier Stentor models may reflect the im-
proved understanding of nitinol processing and the impor-
tance of surface treatments, such as electropolishing,25 tita-
nium nitride annealing,26 heat treatments, and nitric acid
passivation27 to create a thin, uniform oxide layer to help
prevent corrosion and increase biocompatibility and long-
term durability of the metal.28
Overall structural integrity of these devices can be
affected by morphologic characteristics of the recipient
vessel, changes in the aneurysm shape over time, or cyclic
loading from aortic pulsations.29,30 Kinking of the graft can
occur from these stresses and has been associated with limb
occlusion and device or modular component migration in
the Stentor/Vanguard model29 and with metal stent frac-
ture of the longitudinal bars in the Talent device.30 In this
report, 18 fractures occurred in the longitudinal nitinol
bars of Talent or Gore stent grafts. These events were
associated with tortuosity of the implant vessels with pre-
sumed increased stress across the nitinol wire.
The remaining metal stent fractures occurred in Palmaz
stainless steel stents (n  5) and high stressed angled
regions of nitinol z-shaped stents (n 19). The cyclic load
from the aortic pulsations can generate enough stress to
cause microcracks, material irregularities on the surface of
metals produced during laser cutting, to propagate and
eventually fracture. Unfortunately, limited in vivo informa-
tion exists on fatigue crack propagation for endovascular
stents. Studies to date have focused on orthopedic or heart
valve implants, which are larger devices and have different
loading patterns.31 Although the metals used today have
high crack propagation thresholds, the strut widths are
thin, approximating 250 m, thereby leaving a small dis-
tance necessary for a microcrack to travel before fracture.32
Fig 7. SEM of explanted endovascular grafts for abdominal aortic aneurysm. A, Vanguard endovascular graft has
platinum wire wound around proximal and distal portions of attachment system to improve radiograph visualization
(40). B, Despite suspected increased potential for metal fatigue and corrosion at interface of these two metals, no such
fatigue was found in nitinol in this 36-month-old implant (200). C, SEM of Talent stent explanted 15 months after
insertion. Site depicts crimped region of two ends of metal bar. No significant wear or pitting was detected on surface
of nitinol stent at this presumably high risk area for fatigue (40). D, High-powered (4K) magnification of surface of
Talent nitinol spring after explantation. Rough-appearing, uniform oxide layer is discerned.
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Fabric fatigue
All five explanted stent grafts had evidence of fabric
fatigue. Although degradation of conventional polyester
grafts has been reported, it usually occurs 10 to 20 years
after implantation.33 The fabric wear seen in endovascular
stent grafts occurs much earlier. The pulsatile flow of the
aorta and the configuration of the stent graft allows for
micromotion of the individual metal stents against the
fabric leading to eventual breakdown and graft wear. Fabric
fatigue was one of the first reported causes of aneurysm
rupture and stent graft failure in the earlier Stentor graft.2
External abrasions of the fabric on the metal stent and frank
graft holes have been described.24,33,34
In the Stentor and Vanguard devices, the stent is at-
tached to the graft at the proximal and distal ends only
allowing for continuous motion between the stent and the
graft. Fewer examples of graft fenestrations have been
reported with the Talent design, whose stent is completely
fixed to the graft with sutures, thereby reducing the move-
ment between the graft and the nitinol stent. In the one
patient whose device was explanted immediately on open
conversion and in which fabric fatigue was seen, micromo-
tion of the Vanguard device is unlikely to have caused the
failure. Fatigue had to have occurred during manufacturing
or packaging of the device into the deployment catheter.
Theoretically, if the stent graft is drawn into the catheter
from the opposite direction from which it will be deployed,
the angled points of the stents can press firmly against the
graft fabric, potentially causing a small tear or hole.
Suture breakage
Polypropylene sutures that are used to assemble the Sten-
tor/Vanguard device may also be subject to fatigue. Micro-
motion of the individual nitinol stents causes friction and wear
of the sutures, with ultimate suture fracture and stent row
separation. As of January 2001, there has been a 21% preva-
lence rate of row separation reported in the Vanguard mod-
el.35 Of the 14 suture disruptions that were identified in this
report, five were row separations and nine occurred in the
body; this finding is in support of Riepe’s hypothesis that there
is more motion in the larger frames of the body stents.3
Besides the intrinsic properties of the materials used for
stent graft fabrication and the extrinsic hostile environment
of the native aorta, other factors could play a role in device
fatigue. Twenty-four of the 60 patients (40%) in this report
were diagnosed with endoleaks during the follow-up pe-
Fig 8. EDS of explanted Talent graft. A, Marked decrease in nickel peak is discerned in area containing defect in
relatively uniform oxide layer. B, In subjacent region to that irregular area described in A, normal titanium to nickel
distribution is identified.
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riod. The precise time of device failure and endoleak for-
mation is often impossible to determine; however, only five
patients were found to have metallic fractures before the
onset of the endoleak. The remaining 19 patients had an
endoleak develop followed by metallic fracture or had both
events simultaneously discovered. Endoleaks have been
shown to maintain pressure and turbulent flow in the
aneurysm sac, leading to eventual enlargement of the an-
eurysm and risk for rupture.6,37 The residual aneurysm sac
pressure may be communicated to the stent graft itself in
the form of increased device pulsatility that can lead to
metallic fracture, suture disruption, and fabric wear, result-
ing in stent graft device fatigue.
Although most authors agree in the significance of a type
I or type III endoleak contributing to aneurysm dilatation and
risk of eventual rupture, the role a type II endoleak has is less
clear.38-40 In this study, there were seven type II endoleaks, six
of which were diagnosed before the stent graft fracture. All six
of these endoleaks were observed on average 20 months
(range, 6 to 32 months) before diagnosis of the stent graft
fracture. One can hypothesize that although a type II en-
doleak may not generate enough pressure to cause aneurysm
dilatation and rupture, that there is enough pulsatile flow to
expose the stent graft to excess micromotion, which in turn
could lead to device fatigue.
Clinical significance
Although fractures were found in 60 patients with endo-
vascular stent grafts, most of the patients has been asymptom-
atic and have not as of yet needed interventions for device
fatigue. Although three patients had symptomatic aneurysms
develop in the setting of stent fractures, it is unclear whether
these events were related to the fatigued stents. One patient
with an immediate type III leak (graft hole) after implantation
died after open conversion as a consequence of that leak. This
adverse event is assumed to be device related. Concern regard-
ing fractured stent erosion through the fabric of stent grafts
remains; however, this event has not been clearly identified in
this study. At this time, we recommend that if a patient is
asymptomatic and there is no evidence of aneurysm enlarge-
ment, rupture, or a type I or III endoleak, observation of the
stent graft fatigue is acceptable in the setting of increased graft
surveillance.
CONCLUSION
Endovascular grafts have been clinically used to treat
aortic aneurysms for more than 10 years. A significant growth
in the understanding of the failure modes of the materials used
to fabricate these devices and a respect for the relatively harsh
environment into which they must function has led to the
development of improved stent graft designs. Endovascular
graft devices may experience metal fracture, fabric erosion,
and ultimate device fatigue as a result of these two compo-
nents. Stent graft packaging into delivery catheters, steriliza-
tion, and shelf aging may all further impact the occurrence and
timing of device integrity failure. Improved manufacturing
practices can decrease the frequency of these fatigue events;
however, clinical implications of many forms of device fatigue
remains to be defined.
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DISCUSSION
Dr Piergiorgo Cao (Perugia, Italy). Material fatigue is a
central issue in stent graft durability. I have a few questions.
Did you hypothesize that the degradation of the material was
dependent more from the lenghth of the follow-up done than from
the structural characteristic of the endografts? So, was it more time
dependent than structural dependent?
Did you correlate any difference between internal and external
stenting of the graft? The external nitinol can be separated from the
bloodstream and therefore protected from degradation.
Another important issue is the connection between the fabric
and the stent. I found in your abstract that the Excluder graft, in
which the stent is not sutured but embedded inside the PTFE, was
more degradative and presented more mechanical failure. I wonder
if you have any explanation for that.
Dr Tikva S. Jacobs. In our study, we only had three ex-
planted devices that had evidence of fabric erosion, so it is a little
difficult to draw any conclusions from that. But of those three
grafts that had the fabric erosion, they were both in nitinol and
Dacron materials and both of them were in devices that had a
nitinol endoskeleton.
Dr Richard P. Cambria (Boston, Mass). Dr Jacobs, it was a
wonderfully illustrated presentation, obviously with a long experi-
ence.
My question may be somewhat repetitive to Dr Cao’s, but it
was a little difficult to follow in terms of the different types of grafts.
Do your findings have implications for either graft material, poly-
ester versus PTFE? And with particular reference to your home-
made system, we saw the overall data there, but how about the
comparisons between polyester and PTFE?
And to reiterate the question, in your summary data, does this
have design implications for whether or not an exoskeleton or an
endoskeleton is preferred?
Dr Jacobs. To answer your first question about Dacron
versus PTFE, again, we only had five explanted devices to really
analyze the material, and only three of them had evidence of fabric
erosion. All three were in Dacron devices. We did not find any
evidence of fabric erosion in the PTFE.
In reference to the design with endoskeletons versus exoskel-
etons, the majority of our device fatigue was actually in metal stent
fracture. Seventy-two percent of our device fatigues were metal
stent fractures. And it did not really matter whether it was an
endoskeleton or an exoskeleton. What we noticed is that the
majority of them were either in the longitudinal bars of the metal
stents or at the point, the apex, of the z-shaped stents. And it is
most likely the metal stent fracture that is secondary to cyclic
loading and stress.
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